657 related articles for article (PubMed ID: 18687476)
1. Increased X-linked inhibitor of apoptosis protein (XIAP) expression exacerbates experimental autoimmune encephalomyelitis (EAE).
Moore CS; Hebb AL; Blanchard MM; Crocker CE; Liston P; Korneluk RG; Robertson GS
J Neuroimmunol; 2008 Oct; 203(1):79-93. PubMed ID: 18687476
[TBL] [Abstract][Full Text] [Related]
2. Inhibitor of apoptosis protein (IAP) profiling in experimental autoimmune encephalomyelitis (EAE) implicates increased XIAP in T lymphocytes.
Moore CS; Hebb AL; Robertson GS
J Neuroimmunol; 2008 Jan; 193(1-2):94-105. PubMed ID: 18055022
[TBL] [Abstract][Full Text] [Related]
3. Targeted expression of baculovirus p35 caspase inhibitor in oligodendrocytes protects mice against autoimmune-mediated demyelination.
Hisahara S; Araki T; Sugiyama F; Yagami Ki; Suzuki M; Abe K; Yamamura K; Miyazaki J; Momoi T; Saruta T; Bernard CC; Okano H; Miura M
EMBO J; 2000 Feb; 19(3):341-8. PubMed ID: 10654933
[TBL] [Abstract][Full Text] [Related]
4. Blockade of the kinin receptor B1 protects from autoimmune CNS disease by reducing leukocyte trafficking.
Göbel K; Pankratz S; Schneider-Hohendorf T; Bittner S; Schuhmann MK; Langer HF; Stoll G; Wiendl H; Kleinschnitz C; Meuth SG
J Autoimmun; 2011 Mar; 36(2):106-14. PubMed ID: 21216565
[TBL] [Abstract][Full Text] [Related]
5. Bax-ablation attenuates experimental autoimmune encephalomyelitis in mice.
Lev N; Barhum Y; Melamed E; Offen D
Neurosci Lett; 2004 Apr; 359(3):139-42. PubMed ID: 15050683
[TBL] [Abstract][Full Text] [Related]
6. Autoimmunity against myelin oligodendrocyte glycoprotein is dispensable for the initiation although essential for the progression of chronic encephalomyelitis in common marmosets.
Jagessar SA; Smith PA; Blezer E; Delarasse C; Pham-Dinh D; Laman JD; Bauer J; Amor S; 't Hart B
J Neuropathol Exp Neurol; 2008 Apr; 67(4):326-40. PubMed ID: 18379435
[TBL] [Abstract][Full Text] [Related]
7. Experimental allergic encephalomyelitis. T cell trafficking to the central nervous system in a resistant Thy-1 congenic mouse strain.
Skundric DS; Huston K; Shaw M; Tse HY; Raine CS
Lab Invest; 1994 Nov; 71(5):671-9. PubMed ID: 7526038
[TBL] [Abstract][Full Text] [Related]
8. Gp130-dependent astrocytic survival is critical for the control of autoimmune central nervous system inflammation.
Haroon F; Drögemüller K; Händel U; Brunn A; Reinhold D; Nishanth G; Mueller W; Trautwein C; Ernst M; Deckert M; Schlüter D
J Immunol; 2011 Jun; 186(11):6521-31. PubMed ID: 21515788
[TBL] [Abstract][Full Text] [Related]
9. IL-10 mediates resistance to adoptive transfer experimental autoimmune encephalomyelitis in MyD88(-/-) mice.
Cohen SJ; Cohen IR; Nussbaum G
J Immunol; 2010 Jan; 184(1):212-21. PubMed ID: 19949074
[TBL] [Abstract][Full Text] [Related]
10. Astrocytic Fas ligand expression is required to induce T-cell apoptosis and recovery from experimental autoimmune encephalomyelitis.
Wang X; Haroon F; Karray S; Martina Deckert ; Schlüter D
Eur J Immunol; 2013 Jan; 43(1):115-24. PubMed ID: 23011975
[TBL] [Abstract][Full Text] [Related]
11. Gene expression analysis suggests that 1,25-dihydroxyvitamin D3 reverses experimental autoimmune encephalomyelitis by stimulating inflammatory cell apoptosis.
Spach KM; Pedersen LB; Nashold FE; Kayo T; Yandell BS; Prolla TA; Hayes CE
Physiol Genomics; 2004 Jul; 18(2):141-51. PubMed ID: 15138306
[TBL] [Abstract][Full Text] [Related]
12. A myelin oligodendrocyte glycoprotein peptide induces typical chronic experimental autoimmune encephalomyelitis in H-2b mice: fine specificity and T cell receptor V beta expression of encephalitogenic T cells.
Mendel I; Kerlero de Rosbo N; Ben-Nun A
Eur J Immunol; 1995 Jul; 25(7):1951-9. PubMed ID: 7621871
[TBL] [Abstract][Full Text] [Related]
13. Peroxisome proliferator-activated receptor-gamma agonists prevent experimental autoimmune encephalomyelitis.
Feinstein DL; Galea E; Gavrilyuk V; Brosnan CF; Whitacre CC; Dumitrescu-Ozimek L; Landreth GE; Pershadsingh HA; Weinberg G; Heneka MT
Ann Neurol; 2002 Jun; 51(6):694-702. PubMed ID: 12112074
[TBL] [Abstract][Full Text] [Related]
14. Unexpected regulatory roles of TLR4 and TLR9 in experimental autoimmune encephalomyelitis.
Marta M; Andersson A; Isaksson M; Kämpe O; Lobell A
Eur J Immunol; 2008 Feb; 38(2):565-75. PubMed ID: 18203139
[TBL] [Abstract][Full Text] [Related]
15. Induction of experimental autoimmune encephalomyelitis in transgenic mice expressing ovalbumin in oligodendrocytes.
Cao Y; Toben C; Na SY; Stark K; Nitschke L; Peterson A; Gold R; Schimpl A; Hünig T
Eur J Immunol; 2006 Jan; 36(1):207-15. PubMed ID: 16342234
[TBL] [Abstract][Full Text] [Related]
16. Focal experimental autoimmune encephalomyelitis in the Lewis rat induced by immunization with myelin oligodendrocyte glycoprotein and intraspinal injection of vascular endothelial growth factor.
Sasaki M; Lankford KL; Brown RJ; Ruddle NH; Kocsis JD
Glia; 2010 Oct; 58(13):1523-31. PubMed ID: 20645414
[TBL] [Abstract][Full Text] [Related]
17. High interleukin-10 expression within the central nervous system may be important for initiation of recovery of Dark Agouti rats from experimental autoimmune encephalomyelitis.
Blaževski J; Petković F; Momčilović M; Jevtic B; Miljković D; Mostarica Stojković M
Immunobiology; 2013 Sep; 218(9):1192-9. PubMed ID: 23664544
[TBL] [Abstract][Full Text] [Related]
18. Absence of PI3Kgamma leads to increased leukocyte apoptosis and diminished severity of experimental autoimmune encephalomyelitis.
Rodrigues DH; Vilela MC; Barcelos LS; Pinho V; Teixeira MM; Teixeira AL
J Neuroimmunol; 2010 May; 222(1-2):90-4. PubMed ID: 20303183
[TBL] [Abstract][Full Text] [Related]
19. CCR6 regulates EAE pathogenesis by controlling regulatory CD4+ T-cell recruitment to target tissues.
Villares R; Cadenas V; Lozano M; Almonacid L; Zaballos A; Martínez-A C; Varona R
Eur J Immunol; 2009 Jun; 39(6):1671-81. PubMed ID: 19499521
[TBL] [Abstract][Full Text] [Related]
20. Anti-IL-16 therapy reduces CD4+ T-cell infiltration and improves paralysis and histopathology of relapsing EAE.
Skundric DS; Dai R; Zakarian VL; Bessert D; Skoff RP; Cruikshank WW; Kurjakovic Z
J Neurosci Res; 2005 Mar; 79(5):680-93. PubMed ID: 15682385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
